ALBUQUERQUE, N.M. — Prostate cancer is one of the most diagnosed cancers among men. And now, New Mexicans have a new treatment option.
In April of this year, Dr. Sean Tirney, a urologist at Presbyterian Healthcare Services, performed the first surgery in New Mexico using the cutting-edge NanoKnife system.
NanoKnife is a minimally invasive technology that uses electrical pulses to create irreversible electroporation to precisely destroy cancer cells while sparing surrounding healthy tissue. When used to treat prostate cancer, this means there’s a much lower risk of damaging the nerves that control erectile function, and there’s a minimal risk of post procedure incontinence.
“This technology allows us to target and destroy cancer cells with incredible precision, which can significantly reduce side effects that often accompany traditional treatments,” said Dr. Tirney, who was instrumental in bringing the treatment to Presbyterian. “For men diagnosed with prostate cancer, NanoKnife gives us the ability to treat the disease while protecting their quality of life. It’s an exciting advancement in cancer care in New Mexico.”
The NanoKnife procedure is typically performed on an outpatient basis with minimal recovery time. Presbyterian’s use of this technology, which was FDA-approved for prostate cancer treatment in December 2024, reflects its commitment to offering innovative, patient-centered care close to home.
Presbyterian is one of only a limited number of health systems in the country currently offering this treatment. In addition to Dr. Tirney, Drs. Alex Bandin and Ghasem Imani are also performing the procedure at Presbyterian.
Media Inquiries
Our media relations team is available 24/7. Contact us and ask to speak with our media relations team.
